title: Is AL721 really a lipid fluidity modulating agent?
authors.forename: F A
authors.initials: FA
authors.lastname: Offner
authors.forename: K N
authors.initials: KN
authors.lastname: Traill
authors.forename: U
authors.initials: U
authors.lastname: Winter
authors.forename: G
authors.initials: G
authors.lastname: Wick
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology*; D004338:Drug Combinations / Q000494:pharmacology; D005989:Glycerides / Q000494:pharmacology*; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects; D008560:Membrane Fluidity / Q000187:drug effects*; D010713:Phosphatidylcholines / Q000494:pharmacology*; D010714:Phosphatidylethanolamines / Q000494:pharmacology*
chemical_list: D000998:Antiviral Agents; D004338:Drug Combinations; D005989:Glycerides; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; C046637:neutral lipid, phosphatidylcholine, phosphatidylethanolamine drug combination